NYSEARCA:REVS Columbia Research Enhanced Value ETF (REVS) Price, Holdings, & News → Amazon's betting big on this unknown AI company (From Manward Press) (Ad) Free REVS Stock Alerts $23.85 +0.14 (+0.59%) (As of 05:13 PM ET) Add Compare Share Share Today's Range$23.73▼$23.8750-Day Range$22.59▼$23.9752-Week Range$19.29▼$23.98Volume3,583 shsAverage Volume19,924 shsMarket Capitalization$42.93 millionAssets Under Management$50.85 millionDividend Yield2.01%Net Expense Ratio0.19% Stock AnalysisStock AnalysisChartHoldingsOwnershipRatingsStock AnalysisChartHoldingsOwnershipRatings Get Columbia Research Enhanced Value ETF alerts: Email Address About Columbia Research Enhanced Value ETFThe Columbia Research Enhanced Value ETF (REVS) is an exchange-traded fund that mostly invests in large cap equity. The fund tracks an index of US stocks pulled from the Russell 1000 Value Index. REVS index uses multifactor selection and market cap weighting. REVS was launched on Sep 25, 2019 and is managed by Columbia.Read More REVS Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart REVS ETF News HeadlinesFebruary 9, 2024 | msn.comColumbia Banking System declares $0.36 dividendFebruary 1, 2024 | msn.comColumbia Sportswear GAAP EPS of $1.55 misses by $0.41, revenue of $1.06B misses by $20MJanuary 23, 2024 | benzinga.comColumbia Banking System's Earnings OutlookNovember 3, 2023 | investing.comMotilal Oswal S&P BSE Enhanced Value ETF (MOTE)October 23, 2023 | finance.yahoo.comColumbia Research Enhanced Real Estate ETF (CRED)April 13, 2023 | msn.comCaterpillar (CAT) Declares $1.20 DividendMarch 11, 2023 | seekingalpha.comVTV: No Value Left In Value StocksFebruary 22, 2023 | morningstar.comColumbia Overseas Value ASee More Headlines Receive REVS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Columbia Research Enhanced Value ETF and its competitors with MarketBeat's FREE daily newsletter. Email Address Fund Details IssuerColumbia Fund NameColumbia Research Enhanced Value ETF Tax ClassificationRegulated Investment Company Stock ExchangeNYSEARCACurrent SymbolNYSEARCA:REVS Inception Date9/25/2019 Fund ManagerChristopher Lo, Jason Wang WebN/A PhoneN/AFund Focus Asset ClassEquity BenchmarkBeta Advantage Research Enhanced U.S. Value Index CategorySize and Style FocusLarge Cap Development LevelDeveloped Markets RegionNorth America Number of Holdings304 Fund Statistics Assets Under Management$50.85 million Average Daily Volume$0.00 Discount/Premium0.06% Administrator, Advisor and Custodian AdministratorThe Bank of New York Mellon Corporation AdvisorColumbia Management Investment Advisers, LLC CustodianThe Bank of New York Mellon Corporation DistributorALPS Distributors, Inc. Transfer AgentThe Bank of New York Mellon Corporation TrusteeN/A Lead Market MakerJane Street Options OptionableN/A Short Interest100 shs Miscellaneous Outstanding Shares1,800,000Beta0.76 Creation Unit50,000 Creation Fee$500.00 20 Stocks to Sell NowMarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.Get This Free Report Ad Porter & CompanyObama’s Forever Term [exposed]America’s Last Election New documentary, America’s Last Election, reveals the true (and terrifying) story of how the D.C. establishment has engineered a brutal new crisis that could hand them permanent power. Power they will use to reshape America to their dark, dystopian vision.Start streaming it now at no cost here Columbia Research Enhanced Value ETF ExpensesTypeREVSLarge Cap ETFsEquity ETFsNYSEARCA ETFsAll ETFsManagement Fee0.19%0.57%0.54%0.51%0.51%Other Expenses0.00%0.28%0.54%0.64%0.58%Total Expense0.19%0.63%0.70%0.74%0.70%Fee Waiver0.00%-0.19%-0.55%-0.68%-0.57%Net Expense0.19%0.61%0.60%0.58%0.58% Columbia Research Enhanced Value ETF (REVS) Holdings & ExposureTop 10 REVS HoldingsJPMorgan Chase & Co.(NYSE:JPM)Holding Weight: 4.56%Exxon Mobil(NYSE:XOM)Holding Weight: 4.37%Johnson & Johnson(NYSE:JNJ)Holding Weight: 4.04%Procter & Gamble(NYSE:PG)Holding Weight: 3.72%Bank of America(NYSE:BAC)Holding Weight: 3.22%Cisco Systems(NASDAQ:CSCO)Holding Weight: 2.72%Wells Fargo & Company(NYSE:WFC)Holding Weight: 2.64%Financial Select Sector SPDR Fund(NYSEARCA:XLF)Holding Weight: 1.99%Citigroup(NYSE:C)Holding Weight: 1.49%Oracle(NYSE:ORCL)Holding Weight: 1.44%REVS Sector ExposureREVS Industry ExposureFull Holdings Details Similar ETFsELEMENTS Dogs of the Dow Linked to the Dow Jones High Yield Select 10 Total Return IndexNYSEARCA:DODPrincipal Quality ETFNASDAQ:PSETAllianzIM U.S. Large Cap Buffer10 Dec ETFNYSEARCA:DECTProShares S&P 500 Ex-Energy ETFNYSEARCA:SPXEAllianzIM U.S. Large Cap 6 Month Buffer10 Mar/Sep ETFNYSEARCA:SIXPInstitutional OwnershipWealth Enhancement Advisory Services LLCBought 21,141 shares on 4/16/2024Ownership: 1.175%View All Institutional Transactions REVS ETF - Frequently Asked Questions How have REVS shares performed in 2024? Columbia Research Enhanced Value ETF's stock was trading at $21.65 at the beginning of the year. Since then, REVS stock has increased by 9.8% and is now trading at $23.77. View the best growth stocks for 2024 here. What does REVS invest in? Columbia Research Enhanced Value ETF is a equity fund issued by Columbia. REVS focuses on large cap investments and follows the Beta Advantage Research Enhanced U.S. Value Index. The fund's investments total to approximately $50.85 million assets under management. What stocks does Columbia Research Enhanced Value ETF hold? REVS invests in 304 holdings. Some of the stocks in their portfolio include JPMorgan Chase & Co. (JPM), Exxon Mobil (XOM), Johnson & Johnson (JNJ), Procter & Gamble (PG), Bank of America (BAC), Cisco Systems (CSCO), Wells Fargo & Company (WFC), Financial Select Sector SPDR Fund (XLF), Citigroup (C) and Oracle (ORCL). What is the management fee for Columbia Research Enhanced Value ETF? Columbia Research Enhanced Value ETF's management fee is 0.19% and has no other recorded expenses or fee waivers. The net expense ratio for REVS is 0.19%. Who are Columbia Research Enhanced Value ETF's major shareholders? Columbia Research Enhanced Value ETF's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Wealth Enhancement Advisory Services LLC (1.17%). How do I buy shares of Columbia Research Enhanced Value ETF? Shares of REVS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NYSEARCA:REVS) was last updated on 5/15/2024 by MarketBeat.com Staff From Our PartnersTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaBill Clinton Backing Biden Replacement???The Freeport SocietyAmazon's betting big on this unknown AI companyManward PressThis Wall Street stock prediction just went viralChaikin AnalyticsWith revenue forecasted to grow dramatically in 2024 and beyond, this company should be on your radarStocks NewsCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingElon’s New Device is About to Shock the WorldInvestorPlaceGold Set to EXPLODE!Gold Safe Exchange Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Columbia Research Enhanced Value ETF Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.